HSDT
Solana Company
Set alert
2.09 USD -0.17 -7.52%
2.04 Day range 2.15
1.27 52-week range 5.98
- YTD
- -27.68%
- 1 year
- -65.05%
- Open
- 2.15
- Prev close
- 2.26
- Mkt cap
- 136.07M
- Vol
- 562.11K
- Avg vol
- 435.71K
- EPS
- 53.74
- P/E
- 0.04
- Div yield
- 0.00%
More statistics
- Low
- 2.04
- High
- 2.15
- Forward P/E
- -0.40
- Beta
- 1.61
- Short ratio
- 0.34
- Inst. own
- 5.87%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.53168
- 200-d avg
- 1.73
- 1y target
- 0.00
Key statistics
- Market cap
- 3.58M
- Enterprise value
- -4.37M
- Trailing P/E
- 0.00
- Forward P/E
- -0.40
- PEG ratio
- 0.00
- Price / sales
- 6.03
- Price / book
- 0.29
- EPS (TTM)
- -4.27
- Beta
- 1.61
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 594.00K
- Revenue growth
- -28.90%
- Free cash flow
- -5.85M
- Total cash
- 6.39M
- Total debt
- 35.00K
- Return on equity
- -161.97%
- Shares outstanding
- 3.73M
- Short % of float
- 6.38%
- 50-day average
- 0.53168
- 200-day average
- 1.73
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.94.
Financials — quick view
HSDT Revenue — quarterly 2.53M
HSDT Net income — quarterly -30.26M
HSDT EPS — quarterly -0.38
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | -0.99 | — | — |
| Aug 12, 2024 | Jun 1, 2024 | 0.00 | -0.64 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -3.08 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | -4.05 | -1.47 | +2.58 | +63.70% |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -5.49 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | -5.50 | -3.00 | +2.50 | +45.45% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 5, 2024 | Roth MKM | main | Buy | Buy |
About Solana Company
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- heliusmedical.com
News
- Solana Designated As Strategic Enterprise By Hong Kong SAR Government’s Office For Attracting Strategic Enterprises
- Solana Company Selected as a Strategic Enterprise by the Hong Kong SAR Government
- China vs. Crypto Isn’t Over Yet: Solana Company CEO Says Beijing Is Studying the Technology ‘Very Closely’ — 'They Know That's Not the Technology They Can Ignore'
- Head to Head Comparison: PayPal (NASDAQ:PYPL) vs. Solana (NASDAQ:HSDT)
- Solana Co.’s Joseph Chee Tells the Wall Street Journal: China Will Find a Way to Manage Crypto. What Happens If China Reopens?
- Solana Company (HSDT) Now Trades Above Golden Cross: Time to Buy?
- Solana Company (NASDAQ: HSDT) Announces Pricing of $15 Million Registered Direct Offering with a Global Institutional Investor
- Solana (NASDAQ:HSDT) versus Voya Financial (NYSE:VOYA) Head-To-Head Contrast
- B. Riley Securities Maintains Buy on Solana, Raises Price Target to $4
- Is the Options Market Predicting a Spike in Solana Company Stock?
Your note
Sign in to keep a note on HSDT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDREEFF DANE C | Chief Executive Officer | Purchase | Dec 13, 2023 | 0 |
| BUCKMAN PAUL R | Director | Stock Award(Grant) | May 23, 2023 | 89,824 |
| PERKINS SHERRIE L. | Director | Stock Award(Grant) | May 23, 2023 | 90,040 |
| STRAW EDWARD M. | Director | Stock Award(Grant) | May 23, 2023 | 90,111 |
| WALTER BLANE | Director | Stock Award(Grant) | May 23, 2023 | 93,454 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Susquehanna International Group, LLP | 0.49% | 18,223 | 17.49K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.48% | 17,751 | 17.04K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.38% | 14,242 | 13.67K | Sep 29, 2024 |
| Vanguard Group Inc | 0.34% | 12,598 | 12.09K | Sep 29, 2024 |
| UBS Group AG | 0.34% | 12,762 | 12.25K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.13% | 4,792 | 4.60K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.45% | 16,638 | 15.97K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.34% | 12,598 | 12.09K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.12% | 4,530 | 4.35K | Oct 30, 2024 |